Kadimastem Stock Price Prediction
| KMSTF Stock | USD 2.63 0.10 3.95% |
Momentum 37
Sell Extended
Oversold | Overbought |
Using Kadimastem hype-based prediction, you can estimate the value of Kadimastem from the perspective of Kadimastem response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kadimastem to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Kadimastem because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kadimastem after-hype prediction price | USD 2.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kadimastem |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kadimastem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kadimastem After-Hype Price Prediction Density Analysis
As far as predicting the price of Kadimastem at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kadimastem or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kadimastem, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kadimastem Estimiated After-Hype Price Volatility
In the context of predicting Kadimastem's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kadimastem's historical news coverage. Kadimastem's after-hype downside and upside margins for the prediction period are 0.13 and 10.05, respectively. We have considered Kadimastem's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kadimastem is dangerous at this time. Analysis and calculation of next after-hype price of Kadimastem is based on 3 months time horizon.
Kadimastem Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kadimastem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kadimastem backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kadimastem, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.29 | 7.42 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.63 | 2.63 | 0.00 |
|
Kadimastem Hype Timeline
Kadimastem is now traded for 2.63. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kadimastem is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -1.29%. %. The volatility of related hype on Kadimastem is about 0.0%, with the expected price after the next announcement by competition of 2.63. About 54.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be uncertain. Check out Kadimastem Basic Forecasting Models to cross-verify your projections.Kadimastem Related Hype Analysis
Having access to credible news sources related to Kadimastem's direct competition is more important than ever and may enhance your ability to predict Kadimastem's future price movements. Getting to know how Kadimastem's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kadimastem may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OCEL | Ocean Electric | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EMMLF | OKYO Pharma Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OPBXF | OptiBiotix Health Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATHJF | Antisense Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SRNEQ | Sorrento Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PCHM | PharmChem | 0.00 | 0 per month | 2.08 | (0.01) | 2.96 | (2.80) | 17.12 | |
| AMHV | American Hemp Ventures | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NOXOF | Noxopharm Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RTNXF | Renalytix Plc | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 92.50 | |
| VILGF | Yourgene Health Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Kadimastem Additional Predictive Modules
Most predictive techniques to examine Kadimastem price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kadimastem using various technical indicators. When you analyze Kadimastem charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kadimastem Predictive Indicators
The successful prediction of Kadimastem stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kadimastem, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kadimastem based on analysis of Kadimastem hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kadimastem's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kadimastem's related companies.
Story Coverage note for Kadimastem
The number of cover stories for Kadimastem depends on current market conditions and Kadimastem's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kadimastem is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kadimastem's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Kadimastem Pink Sheet analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |